Your browser doesn't support javascript.
loading
miR-122 promotes virus-induced lung disease by targeting SOCS1.
Collison, Adam M; Sokulsky, Leon A; Kepreotes, Elizabeth; Pereira de Siqueira, Ana; Morten, Matthew; Edwards, Michael R; Walton, Ross P; Bartlett, Nathan W; Yang, Ming; Nguyen, Thi Hiep; Johnston, Sebastian L; Foster, Paul S; Mattes, Joerg.
Afiliación
  • Collison AM; Priority Research Centre GrowUpWell, Experimental and Translational Respiratory Medicine Group, School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.
  • Sokulsky LA; Priority Research Centre GrowUpWell, Experimental and Translational Respiratory Medicine Group, School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.
  • Kepreotes E; Priority Research Centre GrowUpWell, Experimental and Translational Respiratory Medicine Group, School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.
  • Pereira de Siqueira A; Priority Research Centre GrowUpWell, Experimental and Translational Respiratory Medicine Group, School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.
  • Morten M; Priority Research Centre GrowUpWell, Experimental and Translational Respiratory Medicine Group, School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.
  • Edwards MR; Airway Disease Infection Section, National Heart and Lung Institute, Medical Research Council & Asthma UK Centre in Allergic Mechanisms of Asthma, Imperial College London, London, United Kingdom.
  • Walton RP; Airway Disease Infection Section, National Heart and Lung Institute, Medical Research Council & Asthma UK Centre in Allergic Mechanisms of Asthma, Imperial College London, London, United Kingdom.
  • Bartlett NW; Airway Disease Infection Section, National Heart and Lung Institute, Medical Research Council & Asthma UK Centre in Allergic Mechanisms of Asthma, Imperial College London, London, United Kingdom.
  • Yang M; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
  • Nguyen TH; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
  • Johnston SL; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
  • Foster PS; Airway Disease Infection Section, National Heart and Lung Institute, Medical Research Council & Asthma UK Centre in Allergic Mechanisms of Asthma, Imperial College London, London, United Kingdom.
  • Mattes J; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
JCI Insight ; 6(7)2021 04 08.
Article en En | MEDLINE | ID: mdl-33830082
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Bronquitis / Infecciones por Picornaviridae / MicroARNs / Proteína 1 Supresora de la Señalización de Citocinas / Enfermedades Pulmonares Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Animals / Female / Humans / Infant / Male Idioma: En Revista: JCI Insight Año: 2021 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Bronquitis / Infecciones por Picornaviridae / MicroARNs / Proteína 1 Supresora de la Señalización de Citocinas / Enfermedades Pulmonares Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Animals / Female / Humans / Infant / Male Idioma: En Revista: JCI Insight Año: 2021 Tipo del documento: Article País de afiliación: Australia